Top Markets
Coin of the day
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA
Classifica tra le azioni #477
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company,... Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Prezzo delle azioni
$19.63
Capitalizzazione di mercato
$47.10B
Variazione (1 giorno)
1.80%
Variazione (1 anno)
-7.33%
Paese
IN
Scambia Sun Pharmaceutical Industries Limited (SUNPHARMA)

Categoria

Utile per Sun Pharmaceutical Industries Limited (SUNPHARMA)
Utile nel Dec 2025 TTM: $1.64B
Secondo gli ultimi rapporti finanziari di Sun Pharmaceutical Industries Limited, gli utili attuali della società sono $1.64B. Nel 2024, la società ha registrato un utile di $1.33B, un aumento rispetto a agli utili del 2023, che erano di $1.14B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Sun Pharmaceutical Industries Limited dal 2004 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $1.64B 2.22%
2025 $1.61B 21.21%
2024 $1.33B 16.34%
2023 $1.14B 93.65%
2022 $588.17M 54.49%
2021 $380.72M -42.58%
2020 $663.01M 20.88%
2019 $548.49M 3.41%
2018 $530.42M -62.03%
2017 $1.40B 40.80%
2016 $992.01M -3.13%
2015 $1.02B 33.99%
2014 $764.30M -3.90%
2013 $795.33M 20.15%
2012 $661.93M 44.90%
2011 $456.82M 45.01%
2010 $315.02M -17.95%
2009 $383.94M -3.94%
2008 $399.69M 107.87%
2007 $192.27M 43.47%
2006 $134.02M 39.03%
2005 $96.39M 9.76%
2004 $87.82M 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$651.61M -60.31%
FR
$3.88B 136.40%
DE
$1.32B -19.32%
JP
$3.36B 104.66%
US
$4.84B 194.62%
GB